Key update sent Voyager Therapeutics (VYGR) stock go bullish in the After-hours

GILD Stock

Voyager Therapeutics (Nasdaq: VYGR) shares dropped -14.73% to $7.7 in the After-market ‎session on Tuesday after the U.S. Neurocrine Biosciences (Nasdaq: NBIX) has been told by ‎the Food and Drug Administration (FDA) that it has put a clinical hold on the NBIb-1817b ‎clinical trial RESTORE-1 (VY-AADC). It was previously disclosed that sites participating in ‎RESTORE-1 […]